Skip to main content
European Commission logo print header

TOPO-TB

Objective

Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.
With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme of
the bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples,
will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resource
adaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detection
at the point of care patient level.

Call for proposal

H2020-SMEInst-2014-2015

See other projects for this call

Sub call

H2020-SMEINST-1-2015

Coordinator

ZYMONOSTICS APS
Net EU contribution
€ 50 000,00
Address
ABOGADE 15
8200 AARHUS N
Denmark

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Danmark Midtjylland Østjylland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00